B- and T-cell markers in opsoclonus-myoclonus syndrome: Immunophenotyping of CSF lymphocytes

Neurology

Volumn 62, Issue 9, 2004, Pages 1526-1532

  Pranzatelli, M R ^a   Travelstead, A L ^a   Tate, E D ^a   Allison, T J ^a   Moticka, E J ^a   Franz, D N ^b   Nigro, M A ^c   Parke, J T ^d   Stumpf, D A ^e   Verhulst, S J ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c Michigan Institute for Neurological Disorders   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY CD45; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER SURGERY; CELLULAR IMMUNITY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LYMPHOCYTE SUBPOPULATION; MALE; MYOCLONUS; NEUROBLASTOMA; NEUROLOGIC DISEASE; OPSOCLONUS; OPSOCLONUS MYOCLONUS SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE; VIDEOTAPE;

EID: 2342553421     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.62.9.1526     Document Type: Article

References (40)

1. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 1962;25:271-276.
2. Pranzatelli MR, Tate ED, Wheeler A, et al. Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia. Pediatr Neurol 2002;27:384-387.
3. Hayward K, Jeremy RJ, Jenkins S, et al. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal anti-bodies. J Pediatr 2001;139:552-559.
4. Pohl KRE, Pritchard J, Wilson J. Neurological sequelae of the dancing eye syndrome. Eur J Pediatr 1996;155:237-244.
5. Pranzatelli MR. The neurobiology of opsoclonus-myoclonus. Clin Neuropharmacol 1992;15:186-228.
6. Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung N-KV, Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol 2003;53:347-353.
7. Pranzatelli MR, Tate ED, Kinsbourne M, Caviness VD Jr, Mishra B. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG. Mov Disord 2002;17:1387-1390.
8. Solomon GE, Chutorian AM. Opsoclonus and occult neuroblastoma. N Engl J Med 1968;279:475-477.
9. Kuban KC, Ephros MA, Freeman RL, et al. Syndrome of opsoclonus-myoclonus caused by Coxsackie B3 infection. Ann Neurol 1983;13:69-71.
10. McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 2001;32:236-242.
11. Boltshauser E, Deonna T, Hirt HR. Myoclonic encephalopathy of infants or "dancing eyes syndrome." Helv Paediatr Acta 1979;34:119-133.
12. Connolly AM, Pestronk A, Shobhna M, Pranzatelli MR, Noetzel MJ. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr 1997;130:878-884.
13. Antunes NL, Khakoo Y, Mattay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 2000;22:315-320.
14. Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1996;19:1-47.
15. Hickey WF. Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 1999;11:125-137.
16. Perrella O, Soscia M, Iaccarino C, Carrieri PB. Cerebrospinal fluid T-cell receptor gamma/delta T lymphocyte subsets in patient with AIDS-dementia complex. J Biol Reg Horm Agents 1992;6:53-56.
17. Nick S, Pileri P, Tongiani S, Uematou Y, Kappos L, De Libero G. T-cell receptor γδ repertoire is skewed in cerebrospinal fluid of multiple sclerosis patients: molecular and functional analyses of antigen-reactive γδ clones. Eur J Immunol 1995;25:355-363.
18. Bieganowski P, Bieganowski K, Zaborski J, Czlonkowska A. Oligoclonal expansion of gamma delta T-cells in cerebrospinal fluid of multiple sclerosis patients. Mult Scler 1996;2:78-82.
19. Dieli F, Sireci G, Di Sano C, et al. Predominance of Vgamma 9/V delta 2 T lymphocytes in the cerebrospinal fluid of children with tuberculosis meningitis: reversal after chemotherapy. Mol Med 1999;5:301-312.
20. Matsubara T, Matsuoka T, Katayama K, et al. Mononuclear cells and cytokines in the cerebrospinal fluid of echovirus 30 meningitis patients. Scand J Infect Dis 2000;32:471-474.
21. Thomas RS, Beuche W, Felgenhauer K. The proliferation rate of T and B lymphocytes in cerebrospinal fluid. J Neurol 1991;238:27-30.
22. Baumgarth N, Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 2000;243:77-97.
23. Pranzatelli MR, Tate ED, Galvan I, Wheeler A. A controlled pilot study of piracetam for pediatric opsoclonus-myoclonus. Clin Neuropharmacol 2001;24:352-357.
24. Svenningsson A, Anderson O, Edsbagge M, Stemme S. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol 1995;63:39-46.
25. SAS Institute Inc. SAS/STAT user's guide, version 8.2, Cary, NC: SAS Institute, 2002.
26. Comans-Bitter WM, De Goot R, Van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-393.
27. Cooper R, Khakoo Y, Matthay KK, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features - a report from the Children's Cancer Group. Med Pediatr Oncol 2001;36:623-629.
28. Nishihara H, Toyoda Y, Tanaka Y, et al. Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution. J Clin Oncol 2002;18:3012-3017.
29. Levinson AI, Sandberg-Wollheim M, Lisak RP, et al. Analysis of B-cell activation of cerebrospinal fluid lymphocytes in multiple sclerosis. Neurology 1983;33:1305-1310.
30. Baig S, Olsson T, Link H. Predominance of Borrelia burgdorferi: specific B cells in cerebrospinal fluid in neuroborreliosis. Lancet 1989;2:71-74.
31. Hayday AC. γδ cells: a right time and right place for a conserved third way of protection. Annu Rev Immunol 2000;18:975-1026.
32. Hafler DA, Fox DA, Manning ME, Schlossman SF, Reinherz EL, Weiner HL. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 1985;312:1405-1411.
33. Girardi M, Oppenheim DE, Steele CR, et al. Regulation of cutaneous malignancy by γδ T-cells. Science 2001;294:605-609.
34. Born W, Cady C, Jones-Carson J, Mukasa A, Lahn M, O'Brien R. Immunoregulatory functions of γδ T-cells. Adv Immunol 1999;71:77-144.
35. Haas W. Gamma/delta cells. Annu Rev Immunol 1993;11:637-685.
36. Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 2000;47:9-17.
37. Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 1998;4:1321-1324.
38. Tanaka M, Tanaka K, Tokiguchi S, Shinozawa K, Tsuji S. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 1999;168:28-31.
39. Eeg-Olofsson O, Prchal JF, Andermann F. Abnormalities of T-lymphocyte subsets in epileptic patients. Acta Neurol Scand 1985;72:140-144.
40. Gupta S, Aggarwal S, Heods C. Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Auton Dev Dis 1996;26:439-452.